
Keto Debate: Is Low-Carb a Game Changer or a Risky Gamble?
With one glaring exception. Recent estimates show that 13 million Americans follow a ketogenic diet – a nutrition paradigm based on extremely low carbs and high fats – and its popularity is only growing.
"This one's hardly a fad, since it's over 100 years old," said Ethan Weiss, MD, a preventive cardiologist at the University of California, San Francisco.
Stores like Costco, Kroger, and Target today advertise "keto-friendly" products to help followers stay the course, and keto snacks are getting more popular among younger consumers. The market size for keto is $13 billion today, and projected to be worth over $16 billion in 2030.
Enthusiasts swear by its health benefits: rapid weight loss, better appetite control, lower blood sugar levels, reduced insulin spikes, and decreased inflammation. "Keto diets have been shown over multiple studies to be beneficial in terms of weight loss and, at least to some degree, in helping the treatment of diabetes," said Weiss.
Yet keto diets directly challenge decades of research showing that consuming high amounts of fat over long periods harms your health, in particular heart health. Unlike more widely recommended eating patterns, such as the Mediterranean diet and DASH (Dietary Approaches to Stop Hypertension), keto is highly restrictive and hard to maintain, and lacks long-term data.
So who's right – mainstream nutrition scientists or keto aficionados? That question has received a lot of attention in recent research. And while a conclusive answer may be years away, current evidence urges caution when it comes to going all in on keto.
Ketones as Fuel
Originally developed in the 1920s as a treatment for epilepsy, the keto diet dramatically reduces how many carbs you eat. This mimics the metabolic effects of fasting, forcing the body into a state of "ketosis" – when the liver starts converting stored fat into ketone bodies (an alternative energy source when glucose, or sugar, is scarce). Doctors found that the diet could significantly make seizures less frequent and less severe, particularly in children who did not respond well to other treatments.
Typically, the U.S. Department of Agriculture recommends people eat a diet consisting of about 45%-65% carbohydrates, 10%-35% protein, and 20%-35% fat. Total calorie intake recommended for Americans is 1,600-2,400 for women and 2,000-3,000 for men.
Following a keto diet means shifting the percentages of fats, carbs, and protein to 70%-80% fat, 5%-10% carbs, and 10%-20% protein. If you eat 2,000 calories a day, that amounts to 20-50 grams of carbs (about two to three slices of bread), 75 grams of protein (10 ounces of beef, chicken, or turkey), and 165 grams of fat (11 tablespoons of peanut butter, or 10 avocados).
Eating fewer carbs reduces glucose levels, prompting your pancreas to produce less insulin. Since insulin promotes fat storage, having less of it helps keep fat from building up. Combined with ketosis, this fat-burning state can make low-carb diets work better for weight loss than low-fat ones, research suggests.
The drastic shift can lead to short-term side effects like fatigue, headaches, crankiness, and brain fog – what some refer to as the "keto flu." This can make the diet hard to follow, as do the very strict guidelines on nutrient proportions. That's part of the reason keto is so appealing to the food industry: Demand is high for products that simplify the preparation of high-fat, low-carb meals.
Still, keto backers say once the first few weeks are over, the flu-like symptoms disappear and meal prep becomes second nature.
But these challenges aside: Is keto truly a healthy choice?
Benefits and Risks of Keto: What the Research Shows
A 2023 big-picture review, published in BMC Medicine and covering 17 meta-analyses of 68 randomized trials, found that keto diets can improve triglycerides, body weight, and blood sugar levels in adults with overweight or obesity – and reduce seizures in patients with epilepsy.
A 2025 study also highlights how cutting carbs and entering ketosis can lower body mass index, waist size, and visceral fat – highlighting the power of keto for weight management.
Other research confirms that the keto diet consistently improves markers of metabolic syndrome – a collection of conditions that raise the risk of heart disease, type 2 diabetes, and stroke. It's also been shown to improve cholesterol levels, reduce inflammation, lower blood pressure, and even slow vascular aging (changes in your blood vessels as you get older).
Yet for all the benefits, research also highlights serious concerns, including nutrient deficiency, increased heart disease risk, and higher levels of LDL cholesterol (the kind that can build up in arteries and cause heart problems). The BMC Medicine review, too, found a significant increase in LDL cholesterol, underscoring the need for long-term trials to assess keto diets' impact on the health of the heart and blood vessels.
"The concern is that ketogenic diets are going to raise the level of your cholesterol, and that will be harmful for your heart in the long term, even if there are short-term benefits related to weight loss," said Sadiya Khan, MD, a professor of cardiovascular epidemiology at Northwestern University Feinberg School of Medicine.
Those happy with their waistline on keto may dismiss the negative effects. "They're trying to convince themselves that what I consider to be an alarming increase in LDL cholesterol is not dangerous," said Weiss. "That's the single biggest drawback as to the long-term safety of these diets."
Cutting way back on carbs means you likely have to sacrifice whole grains, fruits, and vegetables, leading to deficiencies in fiber, vitamins, and antioxidants that supplements can't make up for, said Khan.
Other long-term adverse effects of keto include digestive issues like constipation, bloating, and diarrhea, and a higher risk of kidney stones.
The Best Way to Do Keto
The contradictory findings point to one conclusion: More research, especially long-term, is needed to make sure the keto diet is safe. So far, it seems that the short-term benefits may not offset the long-term risks.
With that in mind, the safest way to make the most of keto may be to take breaks from time to time.
A 2024 study found that sticking to a continuous ketogenic diet might age cells – especially in your heart and kidneys – potentially leading to harmful inflammation. But people in the study who took breaks from the diet didn't have these negative effects.
"The biggest thing we tried to stress is you don't want to be on it for too long," said study author David Gius, MD, PhD, a professor of radiation oncology at University of Texas Health San Antonio. "Take a break. Take a keto vacation."
That means following a keto diet for about four to five days, long enough for most people to enter a state of ketosis, followed by a break of two to three days.
But that's not the only precaution to take, Gius said.
You also need to talk to your doctor and a dietitian before trying keto, as the diet must be tailored to each person, he said. Ask your doctor for a lipid panel and heart panel, along with a thorough cardiac exam, said Gius, who recommended checking back in every three to six months for updated lipid and heart panels.
"Other than the rise in LDL cholesterol, I think keto is safe," said Weiss. He recommends a hybrid model approach: a low-carb, Mediterranean-style diet rich in fruits, vegetables, whole grains, and heart-healthy fats and low in processed foods. Several randomized clinical trials link this eating pattern to a lower risk of chronic diseases, longer lifespan, and the prevention of conditions like heart disease, type 2 diabetes, atrial fibrillation, and breast cancer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
21 minutes ago
- Medscape
CVD Mortality Higher in Women With Inflammatory Diseases
Although cardiovascular disease (CVD)-related mortality decreased significantly from 1999 to 2020 in both men and women with immune-mediated inflammatory diseases (IMIDs), women consistently had higher rates of CVD-related mortality than men over the 22-year period. METHODOLOGY: Researchers analyzed CDC Multiple Cause of Death files from 1999 to 2020 to assess the sex differences in CVD-related mortality in patients with IMIDs. They identified CVD-related deaths with underlying IMIDs in the United States using diagnostic codes. IMIDs such as rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis were analyzed. The analysis included 281,355 IMID-related deaths and 127,149 CVD-related deaths over a period of 22 years. Annual crude and adjusted death rates were estimated. TAKEAWAY: Age-adjusted CVD-related mortality for women with IMIDs declined from 3.3 per 100,000 in 1999 to 1.4 per 100,000 in 2020, whereas the rate in men with IMIDs declined from 2.3 to 1.1 per 100,000 ( P < .01). < .01). However, women had higher mortality than men throughout the study duration (mortality rate ratio, 1.5; P < .01). < .01). Cerebrovascular disease and ischemic heart disease were major causes of death, with women more affected than men; women experienced mortality from arrhythmia and cardiac arrest at more than twice the rate of men. Among patients with IMIDs, women with rheumatoid arthritis had disproportionately higher crude CVD-related mortality than men with rheumatoid arthritis. IN PRACTICE: 'Addressing these risks requires increasing awareness of atypical cardiovascular symptoms in females with IMIDs, enhancing early detection through advanced imaging, and ensuring equitable access to therapies like biologics,' the study authors wrote. SOURCE: This study was led by Issam Motairek, MD, Cleveland Clinic, Cleveland. It was published online on May 5, 2025, in Circulation: Cardiovascular Quality and Outcomes . LIMITATIONS: The potential inaccuracies in the codes for identifying the cause of death may have misclassified IMIDs or CVD-related causes. The aggregate data structure prevented the analyses of individual-level factors such as severity of disease or treatments. Less common IMIDs were excluded, which may have underestimated their contribution to CVD. DISCLOSURES: This study received no specific funding. The authors reported having no conflicts of interest.
Yahoo
23 minutes ago
- Yahoo
Watch These AMD Price Levels as Stock Jumps to Highest Level Since January
Advanced Micro Devices shares closed at their highest level since January on Monday, lifted by optimism that trade discussions between the U.S. and China could lead to reduced export curbs. After breaking out from a descending broadening formation last month, AMD shares have traded mostly sideways just below the closely watched 200-day moving average. Investors should monitor major overhead areas on AMD's chart around $123, $145 and $175, while also watching a key support level near $ Micro Devices (AMD) shares will likely remain in focus after hitting their highest level since January on Monday, lifted by optimism that trade discussions between the U.S. and China could lead to reduced export curbs. Chipmakers rallied after White House National Economic Council Director Kevin Hassett said on CNBC early Monday that officials from Washington and Beijing intended to discuss the release of rare earth minerals to the U.S. and the expansion of Chinese access to American-made semiconductors during talks between the two countries taking place in London this week. In April, AMD cautioned its results would be affected by charges of roughly $800 million related to tightening restrictions on sales of its chips to China, while rival AI behemoth (NVDIA) warned it would take a potential $5.5 billion charge related to limits on exports of its H20 chip. AMD shares gained nearly 5% on Monday to close at around $122. The stock has risen nearly 60% from its early April-low, putting it back to where it started 2025, as investors assess whether the company can make further inroads into the booming AI chip market. Investors will learn more about AMD's plans for artificial intelligence at the company's "Advancing AI" event on Thursday, which features a keynote address from CEO Lisa Su. Below, we take a closer look at AMD's chart and use technical analysis to identify major price levels that investors will likely be monitoring. After breaking out from a descending broadening formation last month, AMD shares have traded mostly sideways just below the closely watched 200-day moving average (MA). More recently, the stock's price has nudged toward the May high, a move that has coincided with the relative strength index indicating strengthening price momentum. It's also worth pointing out that the shares registered their highest trading volume in nearly a month on Monday, indicating growing interest in the chipmaker's stock. Let's identify three major overhead areas on AMD's chart to monitor if the shares continue to trend higher and also locate a key support level worth watching during possible retracements. The first overhead area to monitor sits around $123. This area may provide resistance near the May swing high, which also closely aligns with last year's prominent early-August sell-off swing low. A decisive close above the 200-day MA could spark a rally toward $145. The shares may run into selling pressure in this location near a trendline that connects a range of corresponding trading activity on the chart between April and December last year. Further buying could see the stock's price test higher overhead resistance around $175. Investors who have accumulated shares at lower levels may decide to lock in profits in this region near notable peaks that developed on the chart in May and October 2024. During retracements in the stock, investors should keep a close eye on the $108 level. This area on the chart would likely attract buying interest near last month's pullback low and the stock's early-February trough. The comments, opinions, and analyses expressed on Investopedia are for informational purposes only. Read our warranty and liability disclaimer for more info. As of the date this article was written, the author does not own any of the above securities. Read the original article on Investopedia
Yahoo
26 minutes ago
- Yahoo
JPD's co-responder unit saves $950K yearly with new approach
JOPLIN, Mo. — The Joplin City Council learns about early successes of a new program at the police department. It's called the Joplin Police Department Co-Responder Unit or CRU. The program started back in October. The goal is to address social and behavioral health concerns, and to separate those dealing with a crisis and those committing an actual crime. During a work session Monday (6/9), council heard a presentation by Joplin Police Chief, Dr. Richard Pearson and others, regarding the success of the CRU program. CRU now has three full-time employees, thanks to a partnership with Ozark Center. It's expected to save at least $950,000 annually, through reduced hospitalizations, decreased jail bookings, and time saved by police officers who can now focus their efforts on issues involving crime. 'If we can keep a person from being homeless, if we can keep that person from being in the emergency room, if we can get that person housed, if we can get that person back up and running and becoming a productive member of society again, instead of that person committing crimes,' said Dr. Pearson. 'You know, two groups of people who can't say no are those who run ERs and those who have a jail. So, it's incredibly important that we're able to show that not only are we doing the right thing and that we can feel good as a community about doing the right thing, but that it's also fiscally responsible,' said Ozark Center Chief Clinical Officer, Del Camp. The JPD Co-Responder Unit is currently operating on grant funding. However, following Monday's presentation, council directed city staff to find room in the budget to keep the program operating and growing. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.